Portfolio Companies | Former Portfolio Companies

ExSAR (formerly Carta Proteomics) is focused on providing a technology to determine the efficient protein / protein-binding sites into a drug discovery platform. ExSAR is soon developing chaperones for diseases that are a function of misfolded proteins.(www.exsar.com)

Immunicon has developed and utilizes a magnetic separations technology for rare cell detection. The initial market for this technology is early detection of circulating cancer cells in blood. (www.immunicon.com)

PharmaStem (formerly Biocyte) is focused on sourcing stem cells from umbilical cord blood as an an important alternative to cells from bone marrow and peripheral blood for treatment of cancers, immune-specific diseases and gene therapy.

Sepracor (SEPR) is a specialty pharmaceutical company focusing on intellectual properties based on the purification of isomers and their metabolites. The Company has filed for patents on the purified forms of approximately 30 major drugs. They are marketing several of these compounds directly with major pharmaceutical companies. Sepracor markets a drug, Lunesta, for sleep directly to doctors. (www.sepracor.com)

Targent Inc. focuses on the repositioning and reformulation of older cancer therapeutics and is screening a range of new compounds for novel hits. Targent was sold to Spectrum Pharmaceuticals in 2006. (www.spectrumpharm.com)

Vela Pharmaceuticals is focused on the identification, development, and marketing of therapeutics for psychiatric and behavioral disorders. Vela was sold to Pharmos (PARS) in 2006. (www.pharmoscorp.com)

i-STAT: (STAT) Develops and manufactures pocket-sized clinical chemistry analyzers and disposables providing accurate, real-time measurements of blood analytes for point-of-care testing. IStat was sold to Abbott Laboratories. (www.i-stat.com)

Sonomed is a leading manufacturer of ultrasonic diagnostic instrumentation for ophthalmic indications. Sonomed was sold to Escalon in 1999. (www.escalonmed.com)